Physician profile
Jonathan D Nelson
NPI 1265882070
$6,483.05
in general payments reported to CMS, 2019-2025
30 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,087 · 2022: $2,462 · 2023: $1,138 · 2024: $744 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,656 · Consulting Fee: $200 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,655.66 |
| Consulting Fee | $200.00 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,223.86 | 2022-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $1,115.09 | 2021-2025 | Breztri, Tezspire, Fasenra |
| Mylan Specialty L.P. | $847.58 | 2021-2024 | Yupelri |
| United Therapeutics Corporation | $626.00 | 2021-2025 | Tyvaso, Tyvaso, Orenitram |
| Glaxosmithkline, LLC. | $603.50 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $239.71 | 2021-2023 | |
| Axsome Therapeutics, INC. | $211.40 | 2023-2025 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $171.51 | 2021-2025 | Dupixent |
| Amgen INC. | $167.69 | 2021-2023 | Tezspire |
| Genzyme Corporation | $164.45 | 2021-2025 | |
| Viatris Specialty LLC | $147.68 | 2025 | Yupelri |
| Sanofi-Aventis U.S. LLC | $136.47 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $134.48 | 2021-2025 | Winrevair |
| Takeda Pharmaceuticals U.S.A., INC. | $128.82 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $93.32 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $68.73 | 2022-2024 | Wakix |
| Teva Pharmaceuticals USA, INC. | $54.80 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $52.85 | 2024-2025 | Lumryz |
| Hologic Sales and Service, LLC | $52.44 | 2024 | Myosure Tissue Removal Device |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.53 | 2021-2022 | |
| Insmed, INC. | $31.66 | 2025 | Arikayce |
| Philips North America LLC | $31.06 | 2023-2025 | Vest Therapy Und |
| Grifols USA, LLC | $27.98 | 2025 | Prolastin-C Liquid |
| Boston Scientific Corporation | $21.72 | 2022 | |
| Abbvie INC. | $19.78 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.72 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.12 | 2024 | Zoryve |
| Xeris Pharmaceuticals, INC. | $15.27 | 2021 | |
| Optinose US, INC. | $14.60 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.